Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $723.18 billion, total revenue of $163.73 billion and a weighted average PE ratio of 47.62.
Market Cap
723.18B
Revenue
163.73B
Profits
15.19B
PE Ratio
47.62
Profit Margin
9.27%
Dividend Yield
0.20%
51 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 203.50B | 0.40% | 2,009,927 | 43.21B |
| 2 | DHR | Danaher Corporation | 149.70B | -0.88% | 4,146,622 | 24.01B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 50.83B | -0.30% | 275,432 | 4.04B |
| 4 | A | Agilent Technologies, Inc. | 40.23B | 0.58% | 1,505,961 | 6.79B |
| 5 | IQV | IQVIA Holdings Inc. | 34.77B | -0.58% | 1,496,602 | 15.70B |
| 6 | MTD | Mettler-Toledo International Inc. | 27.79B | -0.76% | 154,760 | 3.87B |
| 7 | NTRA | Natera, Inc. | 24.94B | 0.64% | 997,909 | 1.96B |
| 8 | LH | Labcorp Holdings Inc. | 23.76B | 0.79% | 453,315 | 13.48B |
| 9 | DGX | Quest Diagnostics Incorporated | 21.19B | 1.44% | 983,923 | 10.52B |
| 10 | WAT | Waters Corporation | 19.92B | -0.08% | 446,557 | 3.05B |
| 11 | MEDP | Medpace Holdings, Inc. | 14.84B | 1.32% | 176,247 | 2.23B |
| 12 | ILMN | Illumina, Inc. | 14.68B | -0.47% | 1,112,323 | 4.28B |
| 13 | ICLR | ICON Public Limited Company | 14.39B | -1.79% | 777,834 | 8.09B |
| 14 | EXAS | Exact Sciences Corporation | 11.59B | -0.10% | 2,151,899 | 2.94B |
| 15 | RVTY | Revvity, Inc. | 10.84B | -0.47% | 1,131,739 | 2.80B |
| 16 | QGEN | Qiagen N.V. | 10.47B | 0.29% | 704,985 | 2.04B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.79B | 2.04% | 1,027,376 | 4.03B |
| 18 | GH | Guardant Health, Inc. | 8.16B | -2.98% | 1,685,476 | 828.85M |
| 19 | RDNT | RadNet, Inc. | 5.92B | -0.59% | 443,039 | 1.91B |
| 20 | SHC | Sotera Health Company | 4.59B | -1.04% | 891,497 | 1.12B |
| 21 | WGS | GeneDx Holdings Corp. | 3.47B | 2.13% | 327,707 | 362.32M |
| 22 | HTFL | HeartFlow, Inc. | 2.83B | 0.90% | 115,892 | 148.54M |
| 23 | VCYT | Veracyte, Inc. | 2.82B | 0.06% | 800,646 | 479.13M |
| 24 | GRAL | GRAIL, Inc. | 2.81B | -9.73% | 1,235,178 | 134.29M |
| 25 | TWST | Twist Bioscience Corporation | 1.70B | -8.42% | 2,176,673 | 362.27M |
| 26 | NEO | NeoGenomics, Inc. | 1.30B | -2.24% | 3,051,301 | 689.19M |
| 27 | NEOG | Neogen Corporation | 1.28B | -0.84% | 3,157,487 | 886.89M |
| 28 | OPK | OPKO Health, Inc. | 1.21B | 1.33% | 1,573,503 | 664.03M |
| 29 | PSNL | Personalis, Inc. | 809.62M | -11.19% | 2,055,609 | 80.32M |
| 30 | CDNA | CareDx, Inc | 767.00M | -3.87% | 1,172,297 | 340.83M |
| 31 | MYGN | Myriad Genetics, Inc. | 725.75M | -3.47% | 799,207 | 832.90M |
| 32 | FLGT | Fulgent Genetics, Inc. | 694.21M | -0.53% | 192,337 | 303.22M |
| 33 | CSTL | Castle Biosciences, Inc. | 642.24M | -1.73% | 211,618 | 346.27M |
| 34 | XGN | Exagen Inc. | 253.92M | -2.04% | 181,282 | 58.86M |
| 35 | MDXH | MDxHealth SA | 198.48M | -0.74% | 217,339 | 98.95M |
| 36 | PRE | Prenetics Global Limited | 195.51M | -5.42% | 73,483 | 57.05M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 151.54M | 14.49% | 115,349 | 4.26M |
| 38 | FONR | FONAR Corporation | 97.59M | -0.19% | 16,112 | 104.35M |
| 39 | BNR | Burning Rock Biotech Limited | 86.56M | 0.25% | 10,264 | 74.86M |
| 40 | BDSX | Biodesix, Inc. | 50.08M | -7.63% | 89,552 | 76.56M |
| 41 | NOTV | Inotiv, Inc. | 45.35M | -3.65% | 345,986 | 505.30M |
| 42 | STRR | Star Equity Holdings, Inc. | 38.22M | 1.30% | 2,470 | 137.86M |
| 43 | PRPO | Precipio, Inc. | 27.94M | -7.51% | 22,741 | 21.24M |
| 44 | PRPH | ProPhase Labs, Inc. | 20.77M | 2.88% | 790,075 | 5.59M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 13.20M | -13.78% | 702,621 | 7.68M |
| 46 | CHEK | Check-Cap Ltd. | 10.65M | -12.92% | 204,317 | - |
| 47 | ADVB | Advanced Biomed Inc. | 10.40M | 18.94% | 1,868,557 | - |
| 48 | MYNZ | Mainz Biomed N.V. | 8.07M | 5.67% | 292,547 | 659.94K |
| 49 | XWEL | XWELL, Inc. | 5.73M | -0.50% | 3,495 | 30.60M |
| 50 | NDRA | ENDRA Life Sciences Inc. | 4.61M | -12.43% | 97,810 | - |
| 51 | ISPC | iSpecimen Inc. | 4.10M | -8.33% | 321,238 | 5.91M |